Recombinant Zoster (Shingles) Vaccine: SHINGRIX (GSK)

Shingles is a painful rash caused by reactivation of the chickenpox virus. 99% of people over 50 years of age are living with the virus that causes shingles. One in three people will develop shingles in their lifetime.

SHINGRIX works to boost your body’s protection against shingles (herpes zoster). It is a FDA-approved 2-dose series proven to be up to 90% effective in clinical trials.

It is given as a two-dose series, two months apart.

For more information please follow this link: https://www.cdc.gov/vaccines/hcp/vis/vis-statements/shingles-recombinant.pdf

If you wish to proceed, please sign up here: https://forms.gle/ehw9ojPrQemcg7bP7